Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | USP2 | O75604 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1095520 | 1.00 | FTO (0.43) | FTOKDM4EPOLBMAPTUSP2 | |
| SCHEMBL9915064 | 1.00 | FTO (0.43) | FTOKDM4EPOLBMAPTUSP2 | |
| Hydrochloric Acid SCHEMBL9638604 | 0.99 | FTO (0.42) | FTOKDM4EPOLBMAPTUSP2 | |
| Hydrochloric Acid SCHEMBL12492233 | 0.99 | FTO (0.42) | FTOKDM4EPOLBMAPTUSP2 | |
| SCHEMBL9637519 | 0.97 | FTO (0.43) | FTOKDM4EPOLBMAPTUSP2 | |
| Perchlorate SCHEMBL5605513 | 0.96 | FTO (0.40) | FTOKDM4EPOLBMAPTUSP2 | |
| Perchlorate SCHEMBL29579793 | 0.96 | FTO (0.40) | FTOKDM4EPOLBMAPTUSP2 | |
| Perchlorate SCHEMBL5605515 | 0.96 | FTO (0.40) | FTOKDM4EPOLBMAPTUSP2 | |
| Rhodamine 6G SCHEMBL7454756 | 0.93 | FTO (0.39) | FTOKDM4EPOLBMAPTUSP2 | |
| SCHEMBL13428306 | 0.93 | FTO (0.35) | FTOKDM4EPOLBMAPTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4624903-A1 | LIQUID SPRAY ANALYSIS | Rolls-Royce plc (GB) | 2025-10-01 | — | — | EP | claimed |
| US-20250297956-A1 | LIQUID SPRAY ANALYSIS | ROLLS-ROYCE PLC (GB) | 2025-09-25 | — | — | US | claimed |
| WO-2025058566-A1 | ORALLY-DELIVERED PLATINUM PRO-DRUG AGAINST CISPLATIN-RESISTANT OVARIAN CANCER | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-03-20 | — | — | WO | claimed |
| CN-119499216-A | Traceable mitochondria targeting nano system and preparation method and application thereof | 四川大学 | 2025-02-25 | — | — | CN | claimed |
| EP-4381013-B1 | DYE-EXCHANGED ZEOLITE MARKER | GETTERS SPA (IT) | 2025-02-12 | — | — | EP | claimed |
| CN-118620418-A | Temperature sensitive coating applicable to wind tunnel measurement and preparation method and application thereof | 中国科学院化学研究所 | 2024-09-10 | — | — | CN | claimed |
| US-20230061924-A1 | PHOTOVOLTAIC WINDOW COLOR-CONVERSION LAYERS | Alliance for Energy Innovation, LLC | 2023-03-02 | — | — | US | claimed |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | Floratek Pharma SA (CH) | 2022-12-29 | — | — | US | claimed |
| US-20220389067-A1 | Methods of Treating Neurodegenerative Diseases Caused by G4C2 Expansion in C9ORF72 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-12-08 | — | — | US | claimed |
| CN-115275764-A | Photon nose based on silk micro-nano laser array and preparation method and application thereof | 中国科学院化学研究所 | 2022-11-01 | — | — | CN | claimed |
| EP-4031538-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | Floratek Pharma AG (CH) | 2022-07-27 | — | — | EP | claimed |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | FUSION BIOTECHNOLOGY CO., LTD. (KR) | 2022-05-19 | — | — | US | claimed |
| EP-2519823-B1 | COMPOSITE PROBES AND USE THEREOF IN SUPER RESOLUTION METHODS | US HEALTH (US) | 2022-05-18 | — | — | EP | claimed |
| WO-2022065938-A1 | COMPOUND FOR AGGREGATION-INDUCED EMISSION, COMPOSITION FOR CELL IMAGING USING SAME, AND USE AS CELL-IMAGING CONTRAST AGENT | 아주대학교산학협력단 | 2022-03-31 | — | — | WO | claimed |
| US-20160377605-A1 | LYSOSOMAL ATP SELECTIVE TWO-PHOTON ABSORBING FLUORESCENT PROBE | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2016-12-29 | — | — | US | claimed |
| US-20260130908-A1 | METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4036179-B1 | INK JET RECORDING METHOD AND INK JET RECORDING APPARATUS | CANON KK (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-0349265-A2 | Electroluminescent devices | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-01-03 | — | — | EP | disclosed |
| EP-0281381-A2 | Electroluminescent device with modified thin film luminescent zone | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-09-07 | — | — | EP | disclosed |
| US-4769292-A | Electroluminescent device with modified thin film luminescent zone | EASTMAN KODAK COMPANY (US) | 1988-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160377605-A1 | LYSOSOMAL ATP SELECTIVE TWO-PHOTON ABSORBING FLUORESCENT PROBE | LAMP2, GAA, LAMP1 | FTO 4221/4885KDM4E 4544/4885POLB 2601/4885 |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | BDNF, NTRK2, NGF | FTO 3145/4885KDM4E 3477/4885POLB 1336/4885 |
| US-20260130908-A1 | METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION | SHMT2, NLN, TFAM | FTO 1131/4885KDM4E 1396/4885POLB 2058/4885 |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | TFAM, HSPA9, AIFM1 | FTO 3623/4885KDM4E 3680/4885POLB 506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.